165. Cefiderocol Treatment for Serious Infections Caused by Carbapenem-resistant Bacteria: Post-hoc Analysis of Outcomes by Pathogen in the CREDIBLE-CR Study

BACKGROUND: The efficacy and safety of cefiderocol (CFDC), a novel siderophore cephalosporin, for the treatment of serious infections due to carbapenem-resistant (CR) Gram-negative pathogens was assessed in the CREDIBLE-CR study. The current analysis evaluated clinical and microbiological outcomes b...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Open Forum Infect Dis
Main Authors: Matsunaga, Yuko, Ariyasu, Mari, Takemura, Miki, Yamano, Yoshinori, Toyoizumi, Kiichiro, Kinoshita, Masahiro, Echols, Roger, Den Nagata, Tsutae
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Poster Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7778021/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.475
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki